Mauricio Yonamine

TL;DR: New evidence is brought new evidence supporting the safety and therapeutic value of ayahuasca, dosed within an appropriate setting, to help treat depression, in the first controlled trial to test a psychedelic substance in treatment-resistant depression.

TL;DR: The method proved to be highly precise (coefficient of variation<8%) for all detected substances and confidence parameters of validation of the method were: recovery, linearity, intra- and inter-assay precision as well as limits of detection and quantification of the analytes.

TL;DR: A method was developed and optimized aiming to determinate the herbicides paraquat (PQ) and diquat (DQ) in human plasma and urine samples and can be readily utilized as an important tool to confirm the suspicion of PQ and/or DQ poisoning and evaluate the extent of the intoxication.

TL;DR: Ayahuasca was found to induce a biphasic effect in the brain and effects were significantly associated with circulating levels of ayahuasca’s chemical compounds, mostly N,N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine and some of their metabolites.

TL;DR: A high incidence of truck drivers who tested positive for drug use was found, among other reported health problems, indicating an evident need to promote a healthier lifestyle among professional drivers and a need for preventive measures aimed at controlling the use of drugs by truck drivers in Brazil.